- Home
- ALT vs AZ Comparison
ALT vs AZ Comparison
Compare ALT & AZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALT
- AZ
- Stock Information
- Founded
- ALT 1997
- AZ 2018
- Country
- ALT United States
- AZ Canada
- Employees
- ALT N/A
- AZ N/A
- Industry
- ALT Biotechnology: Pharmaceutical Preparations
- AZ Industrial Machinery/Components
- Sector
- ALT Health Care
- AZ Industrials
- Exchange
- ALT Nasdaq
- AZ Nasdaq
- Market Cap
- ALT 348.6M
- AZ 319.5M
- IPO Year
- ALT N/A
- AZ N/A
- Fundamental
- Price
- ALT $4.15
- AZ $7.24
- Analyst Decision
- ALT Strong Buy
- AZ Strong Buy
- Analyst Count
- ALT 7
- AZ 1
- Target Price
- ALT $16.50
- AZ $20.00
- AVG Volume (30 Days)
- ALT 2.8M
- AZ 425.0K
- Earning Date
- ALT 11-06-2025
- AZ 11-13-2025
- Dividend Yield
- ALT N/A
- AZ N/A
- EPS Growth
- ALT N/A
- AZ N/A
- EPS
- ALT N/A
- AZ N/A
- Revenue
- ALT $20,000.00
- AZ $7,489,000.00
- Revenue This Year
- ALT N/A
- AZ $1,343,857.60
- Revenue Next Year
- ALT N/A
- AZ N/A
- P/E Ratio
- ALT N/A
- AZ N/A
- Revenue Growth
- ALT N/A
- AZ 19.04
- 52 Week Low
- ALT $2.90
- AZ $4.66
- 52 Week High
- ALT $11.16
- AZ $12.36
- Technical
- Relative Strength Index (RSI)
- ALT 58.45
- AZ N/A
- Support Level
- ALT $3.93
- AZ N/A
- Resistance Level
- ALT $4.15
- AZ N/A
- Average True Range (ATR)
- ALT 0.17
- AZ 0.00
- MACD
- ALT 0.01
- AZ 0.00
- Stochastic Oscillator
- ALT 77.42
- AZ 0.00
About ALT Altimmune Inc.
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
About AZ A2Z Smart Technologies Corp.
A2Z Cust2Mate Solutions Corp is engaged in creating shopping carts. With the help of a user-friendly smart algorithm, touch screen, and other technologies, the company streamlines the retail shopping experience by scanning purchased products and enabling in-cart payment so that customers can simply pick & go, and bypass long cashier checkout lines.